Clinical trials: Diphosphonates
Cystic Fibrosis, Osteoporosis
Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis Patients
The primary objective of this study is to determine efficacy of 70 mg alendronate once weekly compared to placebo. This will be measured by percent changes in lumbar spine(LS) bone mineral density(BMD) in adult cystic…
- Conditions
- Cystic Fibrosis, Osteoporosis, Bone Diseases, Metabolic
- Trial name
- NCT00157690
- Testing
- Alendronate
- Where
- 6 sites in Canada
- Volunteers
- 56 people
- Sponsor
- McMaster University